k kumar profile picture
k kumar Erstellt neuen Artikel
2 d - übersetzen

Next-Generation Checkpoint Targets: Commercializing B7-H4 Therapies | #healthcare

Next-Generation Checkpoint Targets: Commercializing B7-H4 Therapies

Next-Generation Checkpoint Targets: Commercializing B7-H4 Therapies

protein's unique immunosuppressive pathways distinguish it from PD-1/PD-L1 and CTLA-4, providing complementary therapeutic options for patients who fail first-line immunotherapie

© 2025 SkTSocial

Sprache